A2AR-D2R二聚化与D2R偏向性信号在PDE10A介导的心肌肥厚中的作用
该研究在血管紧张素II诱导的成年小鼠心肌细胞肥厚模型中,探究PDE10A调控心肌肥厚的信号通路。发现PDE10A失活通过cAMP/PKA依赖方式发挥抗肥厚作用,并揭示A2AR-D2R异二聚体介导βarr2偏向性D2R信号,激活PP2A-B56δ抑制HDAC5核输出。联合PDE10A抑制与A2AR或D2R偏向性激动产生协同抗肥厚效应。
要点
- PDE10A失活的抗心肌肥厚效应特异性依赖cAMP/PKA信号。
- A2AR-D2R异二聚体介导βarr2偏向性D2R信号,拮抗心肌肥厚。
- PDE10A抑制联合A2AR或D2R偏向性激动具有协同抗肥厚作用。
核心结论
- A2AR-D2R二聚化和βarr2偏向性D2R信号是拮抗病理性心肌肥厚和心功能障碍的新机制。
- PDE10A是该信号轴的关键负调控因子。
- 靶向PDE10A、A2AR-D2R/βarr2信号或两者联合可能成为对抗病理性心脏重构的新治疗策略。
研究设计与样本
- 在离体成年小鼠心肌细胞中,用血管紧张素II诱导心肌肥厚,通过细胞表面积和蛋白质合成评估肥厚。
- 通过PDE10A敲除或TP-10抑制实现PDE10A失活。
- 使用多种药理学激动剂/拮抗剂、遗传突变体以及D2R和A2AR敲除模型,在体外和体内研究A2AR-D2R异二聚体及下游信号的作用。
- 利用病毒载体操控关键信号分子的蛋白或shRNA表达。
主要发现
- PDE10A失活的抗肥厚效应特异性依赖cAMP/PKA信号。
- 在心肌细胞中发现A2AR-D2R异二聚体及其与PDE10A的关联。
- A2AR-D2R异二聚体介导βarr2偏向性D2R信号,激活D2R偏向性信号可拮抗心脏肥厚和功能障碍。
- PDE10A缺陷或抑制增强A2AR-D2R异二聚化,通过增加A2AR/cAMP/PKA介导的D2R磷酸化促进βarr2偏向性D2R信号及下游PP2A-B56δ激活。
- PDE10A失活抑制应激信号诱导的HDAC5核输出和磷酸化,且依赖PP2A。
临床怎么用
- PDE10A抑制可能通过增强A2AR-D2R异二聚化和βarr2偏向性D2R信号发挥抗心肌肥厚作用。
- 联合PDE10A抑制与A2AR或D2R偏向性激动可能产生协同抗肥厚效应,提示联合治疗策略的潜力。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pathological cardiomyocyte (CM) hypertrophy is a hallmark of dilated cardiomyopathy and heart failure, driven by mechanical or neurohumoral stress. Although we previously demonstrated PDE10A (phosphodiesterase 10A) as a critical contributor and potential therapeutic target in pathological cardiac remodeling and dysfunction, the underlying mechanisms remain unclear. Here, we investigated the specific signaling pathways and sources of cyclic nucleotides modulated by PDE10A in CM hypertrophy. METHODS: CM hypertrophy was induced by angiotensin II in isolated adult mouse CMs, with hypertrophy assessed by cell surface area and protein synthesis. PDE10A inactivation was achieved through PDE10A knockout or inhibition with TP-10. Various pharmacological agonists/antagonists, genetic mutants, and knockout models of D2R (dopamine receptor D2) and A2AR (adenosine A2A receptor) were used to study the role of A2AR-D2R heterodimer and downstream signaling in CM hypertrophy in vitro and in vivo. Viral vectors were used to manipulate protein or small hairpin RNA expression targeting key signaling molecules. RESULTS: We demonstrated that the antihypertrophic effect of PDE10A inactivation is specifically dependent on cAMP/PKA (protein kinase A) signaling. Importantly, we discovered an A2AR-D2R heterodimer and its association with PDE10A in CMs. The A2AR-D2R heterodimer mediates the βarr2 (beta-arrestin 2)-biased D2R signaling, and activating D2R-biased signaling antagonizes cardiac hypertrophy and dysfunction. PDE10A deficiency or inhibition enhanced A2AR-D2R heterodimerization, promoting βarr2-biased D2R signaling and downstream PP2A (protein phosphatase 2A)-B56δ activation through increased A2AR/cAMP/PKA-mediated D2R phosphorylation. PDE10A inactivation inhibits stress signal-induced HDAC5 (histone deacetylase 5) nuclear export and phosphorylation, which are dependent on PP2A. Genetic and pharmacological approaches in animal models confirmed the critical roles of A2AR-D2R heterodimerization, D2R phosphorylation, and biased D2R signaling in vivo. Furthermore, combining PDE10A inhibition with A2AR or D2R-biased agonism produced synergistic antihypertrophic effects, highlighting their novel therapeutic potential. CONCLUSIONS: Our findings reveal A2AR-D2R dimerization and βarr2-biased D2R signaling as novel and critical mechanisms for counteracting pathological CM hypertrophy and cardiac dysfunction. PDE10A acts as a pivotal negative regulator of this signaling axis. Targeting PDE10A, A2AR-D2R/βarr2 signaling, or both offers potentially novel therapeutic strategies for combating pathological cardiac remodeling and cardiac dysfunction.
引用
- Chen S, Fan X, Xu S, et al. Role of A2AR-D2R Dimerization and D2R-Biased Signaling in PDE10A-Mediated Cardiac Hypertrophy. Circulation. 2025. PMID: 40970278. doi:10.1161/CIRCULATIONAHA.125.075465
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。